[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

De Wit et al., 2018 - Google Patents

Classification of cells in CTC-enriched samples by advanced image analysis

De Wit et al., 2018

View HTML
Document ID
13123678452348640828
Author
De Wit S
Zeune L
Hiltermann T
Groen H
Dalum G
Terstappen L
Publication year
Publication venue
Cancers

External Links

Snippet

In the CellSearch® system, blood is immunomagnetically enriched for epithelial cell adhesion molecule (EpCAM) expression and cells are stained with the nucleic acid dye 4′ 6-diamidino-2-phenylindole (DAPI), Cytokeratin-PE (CK), and CD45-APC. Only DAPI+/CK+ …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume, or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Electro-optical investigation, e.g. flow cytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/01—Social networking
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications

Similar Documents

Publication Publication Date Title
De Wit et al. Classification of cells in CTC-enriched samples by advanced image analysis
Serrano-Pertierra et al. Characterization of plasma-derived extracellular vesicles isolated by different methods: a comparison study
Lowes et al. Circulating tumor cells (CTC) and cell-free DNA (cfDNA) workshop 2016: scientific opportunities and logistics for cancer clinical trial incorporation
Koch et al. Pre-analytical and analytical variables of label-independent enrichment and automated detection of circulating tumor cells in cancer patients
Stevens et al. StarDist image segmentation improves circulating tumor cell detection
Rivera-Báez et al. Expansion of circulating tumor cells from patients with locally advanced pancreatic cancer enable patient derived xenografts and functional studies for personalized medicine
Hu et al. Circulating tumor cells in prostate cancer
Ender et al. Detection and quantification of extracellular vesicles via FACS: membrane labeling matters!
Nanou et al. Scanning electron microscopy of circulating tumor cells and tumor-derived extracellular vesicles
Humphries et al. Improving the diagnostic accuracy of the PD-L1 test with image analysis and multiplex hybridization
Gerdtsson et al. Large extracellular vesicle characterization and association with circulating tumor cells in metastatic castrate resistant prostate cancer
Hou et al. Circulating tumor cells, enumeration and beyond
Muchlińska et al. Detection and characterization of circulating tumor cells using imaging flow cytometry—a perspective study
Salama et al. Artificial intelligence enhances diagnostic flow cytometry workflow in the detection of minimal residual disease of chronic lymphocytic leukemia
Kuvendjiska et al. Non-metastatic esophageal adenocarcinoma: Circulating tumor cells in the course of multimodal tumor treatment
Van de Stolpe et al. Circulating tumor cells: what is in it for the patient? A vision towards the future
Bhakdi et al. Accuracy of tumour-associated circulating endothelial cells as a screening biomarker for clinically significant prostate cancer
Turetta et al. Assessment of the mutational status of nsclc using hypermetabolic circulating tumor cells
Kulasinghe et al. The use of three-dimensional dna fluorescent in situ hybridization (3D DNA FISH) for the detection of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC) circulating tumor cells
Shishido et al. Liquid biopsy landscape in patients with primary upper tract urothelial carcinoma
Leveque et al. Phenotypic and histological distribution analysis identify mast cell heterogeneity in non-small cell lung cancer
Ruiz-Rodríguez et al. Deep phenotypic characterisation of CTCs by combination of microfluidic isolation (IsoFlux) and imaging flow cytometry (ImageStream)
D’amico et al. Single-cells isolation and molecular analysis: focus on HER2-low CTCs in metastatic breast cancer
Nanou et al. Leukocyte-derived extracellular vesicles in blood with and without EpCAM enrichment
Tang et al. Clinical applications of cancer-associated cells present in the blood of cancer patients